or Try an Advanced Search...

    Liver Disease Stocks List

    Symbol Grade Name % Change
    GRI F GRI Bio, Inc. -2.44
    BFRG F Bullfrog AI Holdings, Inc -1.20
    HEPA F Hepion Pharmaceuticals, Inc. -1.92
    TARA F ArTara Therapeutics, Inc. 3.45
    NTLA F Intellia Therapeutics, Inc. 3.61
    GALT F Galectin Therapeutics Inc. -5.70
    ALGS F Aligos Therapeutics, Inc. 5.63
    GYRE F Gyre Therapeutics, Inc. -2.98
    GNFT D GENFIT S.A. 0.00
    GILD C Gilead Sciences, Inc. -2.65
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Health Information Services
    Related Stock Lists: Medicine Artificial Intelligence Autoimmunity Biopharmaceutical Chronic Liver Disease Chronic Liver Diseases Cyclophilin Drug Therapy Fatty Liver Disease Gilead Sciences Hepatitis Hepatitis B Hepatocellular Carcinoma Hepatotoxins Histopathology Human Cancer Human Diseases Immune System Immunology Lipid

    Related ETFs - A few ETFs which own one or more of the above listed Liver Disease stocks.

    Symbol Grade Name Weight
    IBB B iShares Nasdaq Biotechnology Index Fund 8.54
    IBBQ B Invesco Nasdaq Biotechnology ETF 8.47
    BIS D ProShares UltraShort Nasdaq Biotechnology 7.41
    BBH B Market Vectors Biotech ETF 7.21
    GNOM D Global X Genomics & Biotechnology ETF 6.02
    View all Liver Disease ETFs...
    Compare ETFs
    Compare BBH to GNOM Compare IBB to GNOM Compare IBBQ to GNOM

        Liver Disease Stocks Recent News

        Date Stock Title
        Jul 3 GILD 5 FDA decisions to watch in the third quarter
        Jul 3 NTLA Cathie Wood's Ark Invest Sells Tesla Shares Worth $14.5M Amid Rally Driven By Q2 Delivery Numbers, Picks Up Palantir Shares Again Today
        Jul 2 GYRE Gyre Therapeutics Announces China’s NMPA Approval of Avatrombopag Maleate Tablets for the Treatment of CLD-Associated Thrombocytopenia
        Jul 2 GRI GRI Bio Announces Publication of Positive Preclinical Data from Lead Program GRI-0621 in the American Journal of Respiratory and Critical Care Medicine
        Jul 2 NTLA 3 Stocks Cathie Wood Just Bought to Get Back on Track in the Second Half of 2024
        Jul 2 GILD Should You Be Concerned About Gilead Sciences, Inc.'s (NASDAQ:GILD) ROE?
        Jul 2 GILD Insider Sale: Chief Medical Officer Merdad Parsey Sells Shares of Gilead Sciences Inc (GILD)
        Jul 1 GILD Gilead Benefit Helps Employees Navigate Cancer Care
        Jul 1 GRI GRI Bio to Present at the 8th Annual IPF Summit
        Jul 1 GILD Should You Hold Gilead Sciences (GILD)?
        Jul 1 GILD 3 Magnificent Stocks Retirees Can Buy and Hold Forever
        Jun 28 GRI GRI Bio Announces Closing of $4.0 Million Public Offering
        Jun 27 NTLA Intellia (NTLA) Shares Fall as CFO Glenn Goddard Steps Down
        Jun 27 GRI GRI Bio announces pricing of $4 million public offering
        Jun 27 GRI GRI Bio Announces Korea Patent Granted for Proprietary Natural Killer T (NKT) Cell Modulators
        Jun 27 GRI GRI Bio Announces Pricing of $4 Million Public Offering
        Jun 27 GYRE Estimating The Intrinsic Value Of Gyre Therapeutics, Inc. (NASDAQ:GYRE)
        Jun 27 NTLA Cathie Wood's Ark Invest Acquires $7.3M Worth Of Shares In This Promising Netflix Competitor, Sells Off Coinbase Stock Amid Bitcoin Slump
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Health Information Services
        Related Stock Lists: Medicine Artificial Intelligence Autoimmunity Biopharmaceutical Chronic Liver Disease Chronic Liver Diseases Cyclophilin Drug Therapy Fatty Liver Disease Gilead Sciences Hepatitis Hepatitis B Hepatocellular Carcinoma Hepatotoxins Histopathology Human Cancer Human Diseases Immune System Immunology Lipid
        Liver Disease

        Liver disease (also called hepatic disease) is a type of damage to or disease of the liver. Whenever the course of the problem lasts long, chronic liver disease ensues.

        More about Liver Disease
        Browse All Tags